Background: We report a genome linkage scan in extended Utah pedigrees, utilizing a pedigree-splitting approach to reduce intra-familial heterogeneity.
Methods: Fifty-nine pedigrees with at least four Prostate cancer (PrCa) cases and no more than two meioses separating PrCa cases were analyzed using the CIDR genomic search STRP marker set. Parametric linkage analyses using dominant and recessive models were performed on four datasets resulting from a pedigree splitting algorithm. In addition, age at diagnosis subset analyses were performed.
Results: Four regions of interest (LODs>1.9) were identified on chromosomes 1p, 3q, 5q, and 22q. The linkage peaks on 1p, 3q, and 22q have been previously implicated for PrCa, though not significantly. The 1p region was supported by a single large Utah pedigree with a multipoint LOD score of 3.1. An additional 10 regions gave LOD scores>1.22 (nominal linkage evidence), including moderate evidence supporting the HPC20 region with a recessive model.
Conclusions: Our genome-wide search in the informative, extended Utah pedigrees continues to illustrate an ability to identify and replicate linkage peaks, and supports four regions of interest for PrCa predisposition genes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/pros.20287 | DOI Listing |
Cancer Med
December 2024
Division of Public Health, Department of Family and Preventive Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Background: Annual or biennial breast cancer screenings are recommended for women 40 and older. Women residing in rural areas have worse breast cancer survival rates than urban women, but no study has focused on rural versus urban residence in Utah regarding breast cancer screening and mortality.
Methods: Cases (nā=ā14,516) were women aged >ā39 diagnosed with a first primary invasive breast cancer between 1998 and 2017 in Utah.
G3 (Bethesda)
December 2024
Department of Human Genetics, The University of Utah, Salt Lake City, UT 84112, USA.
Am J Obstet Gynecol
December 2024
Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT; Intermountain Healthcare, Maternal-Fetal Medicine, Salt Lake City, UT.
Cancer Med
November 2024
Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Objective: To evaluate the validity of the Utah statewide All-Payer Claims Database (APCD), we compared breast cancer-specific treatments and dosages with gold-standard abstraction of medical records.
Study Design: In this pilot study, breast cancer treatments were abstracted by a certified tumor registrar at the Utah Cancer Registry (UCR) for patients diagnosed in 2013 with breast cancer. The abstraction of medical records was the gold standard for comparison with treatments identified in the APCD.
Oral Oncol
December 2024
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, Utah, United States. Electronic address:
Objectives: The incidence of oropharyngeal cancer continues to rise in the United States, yet studies on the quality of life (QoL) of oropharyngeal cancer patients are limited. The objective of this pilot study was to assess the impact of oral health on the QoL in oropharyngeal cancer survivors.
Materials And Methods: Oropharyngeal cancer survivors with a confirmed cancer diagnosis from 1996 to 2016 were sampled from the Utah Cancer Registry.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!